How Can I Be Immune To Measles And Rubella But Not Mumps

Immunization Safety Review

The Immunization Safety Review Committee was established by the Institute of Medicine (IOM) to evaluate the evidence on possible causal associations between immunizations and certain adverse outcomes, and to then present conclusions and recommendations. The committee's mandate also includes assessing the broader societal significance of these immunization safety issues. While all the committee members share the view that immunization is generally beneficial, none of them has a vested interest in the specific immunization safety issues that come before the group. The committee reviews three immunization safety review topics each year, addressing each one at a time. In this fifth report in a series, the committee examines the hypothesis that exposure to polio vaccine contaminated with simian virus 40 (SV40), a virus that causes inapparent infection in some monkeys, can cause certain types of cancer.

Rubella Surveillance

Comprehensive Review of Infectious Diseases

With complete coverage of the most frequently encountered concepts and conditions in infectious disease, Comprehensive Review of Infectious Diseases, Second Edition, is perfect for board review or quick reference in clinical practice. This balanced, high-yield resource uses a high-yield, bulleted outline format of the entire field, with summary tables, boxes, key figures, clinical pearls, mnemonics and memory aids—exactly the information you need for exam preparation or a concise clinical review. This updated second edition has been edited and written by authors who have recently taken the boards and excelled, and who understand the challenges posed by this complex field of study and practice. - Covers challenging areas frequently covered on the boards: clinically-relevant microbiology and ID pharmacology, HIV and antiretroviral therapy, infections in immunocompromised hosts, dermatologic manifestations of ID, infection mimics, infection control and prevention, and more. - Includes expanded information on respiratory infections, including COVID-19; new classification of fungal disease; and emerging topics such as neglected tropical diseases, bioterrorism, and emerging and re-emerging infections. - Facilitates quick review and maximum retention of information by including hundreds of high-quality illustrations, tables, high-yield boxes, and bulleted lists. - Contains coverage of all of the topics listed in core ID exam blueprints, as well as practical tips for taking the boards, an ID Memory Aid chapter with flashcards, clinical and board pearls, and more. - Any additional digital ancillary content may publish up to 6 weeks following the publication date.